Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 9,166 | 9,003 | 10,342 | 10,633 | 8,122 |
| Operating Income | -9,166 | -9,003 | -10,342 | -10,633 | -8,122 |
| Interest Expense | 835 | 650 | 460 | 308 | 269 |
| Other Income | -427 | 539 | -725 | 307 | -206 |
| Pre-tax Income | -10,428 | -9,114 | -11,527 | -10,634 | -8,597 |
| Net Income Continuous | -10,428 | -9,114 | -11,527 | -10,634 | -8,597 |
| Net Income | $-10,428 | $-9,114 | $-11,527 | $-10,634 | $-8,597 |
| EPS Basic Total Ops | -0.24 | -0.15 | -0.19 | -0.18 | -0.14 |
| EPS Basic Continuous Ops | -0.17 | -0.15 | -0.19 | -0.18 | -0.14 |
| EPS Diluted Total Ops | -0.24 | -0.15 | -0.19 | -0.18 | -0.14 |
| EPS Diluted Continuous Ops | -0.17 | -0.15 | -0.19 | -0.18 | -0.14 |
| EBITDA(a) | $-9,158 | $-9,019 | $-10,310 | $-10,625 | $-8,115 |